A Possibility of Vasospastic Angina after mRNA COVID-19 Vaccination

A Possibility of Vasospastic Angina after mRNA COVID-19 Vaccination

We report a case of vasospastic angina (VSA) following COVID-19 mRNA vaccination. Despite the widespread occurrence of myocarditis, there have been few reports of post-vaccinal VSA. A 41-year-old male patient was referred for chest pain at rest following mRNA vaccination; he had never experienced ch...

Celý popis

Podrobná bibliografie
Hlavní autoři: Toru Awaya, Masao Moroi, Fuminori Nakamura, Satoru Toi, Momoko Wakiya, Yoshinari Enomoto, Taeko Kunimasa, Masato Nakamura
Médium: Článek
Jazyk:English
Vydáno: MDPI AG 2022-11-01
Edice:Vaccines
Témata:
COVID-19 vaccination
cardiovascular diseases
vasospastic angina
adverse reaction
inflammatory cytokine
lipid nanoparticles
On-line přístup:https://www.mdpi.com/2076-393X/10/12/1998

Internet

https://www.mdpi.com/2076-393X/10/12/1998

Podobné jednotky